UnknownNCT03499782

Precise Treatment System of Biliary Malignancies Based on Special Disease Database

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Principal Investigator
Zhimin Geng, MD,PhD
the first affiliated hospital of xi'an Jiaotong univerisity
Enrollment
10000 target
Eligibility
18-80 years · All sexes
Timeline
2018 – 2021

Study locations (1)

Collaborators

First Affiliated Hospital Xi'an Jiaotong University · The First Affiliated Hospital of Zhengzhou University · The First Affiliated Hospital of Dalian Medical University · Shanghai Zhongshan Hospital · Southwest Hospital, China · Tianjin Medical University Cancer Institute and Hospital · Sun Yat-sen University · Affiliated Hospital of North Sichuan Medical College · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Second Affiliated Hospital, School of Medicine, Zhejiang University · Eastern Hepatobiliary Surgery Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03499782 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma →

← Back to all trials